Kosnopfel C, Sinnberg T, Sauer B, et al. MAPK inhibitor resistant melanoma cells can be effectively targeted by inhibition of the p90 ribosomal S6 kinase. SMR 2017, abstract P01-9.
Adjuvant alectinib verbetert DFS, maar effect op OS nog onduidelijk
mei 2024 | Longoncologie